BAJAJ BROKING

Notification
No new Notification messages
Balaji Phosphates IPO is Open!
Apply for the Balaji Phosphates IPO through UPI in just minutes.
Q3 FY'25 Results of Top Companies!
From Reliance Industries to TCS to HDFC Bank, check out the latest quarterly results with financial highlights, key performance metrics, and more!
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Dr Agarwal's Health Care Ltd

Healthcare

Offer Period :

29th to 31st Jan 2025

Dr Agarwal's Health Care Ltd IPO Details

IPO Date 29th to 31st Jan 2025 Minimum Investment ₹14070 / 1 Lots
Listing Date 2025-02-04 Maximum Investment ₹196980 / 14 Lots
Face Value ₹1 per share Total Issue Size ₹3027.26 Crores
Price ₹402 to ₹402 per share Fresh Issue ₹300 Crores
Lot Size 1 Lots (35 Shares) Offer For Sale ₹ [-]
Listing At BSE, NSE Retail Discount ₹ 0
Employee Discount ₹0 per Share Shareholding Pre Issue 308417160 Shares
Issue Type Book Building Shareholding Post Issue 315879846 Shares
IPO Date 29th to 31st Jan 2025
Listing Date 2025-02-04
Face Value ₹1 per share
Price ₹402 to ₹402 per share
Lot Size 1 Lots (35 Shares)
Listing At BSE, NSE
Total Issue Size ₹3027.26 Crores
Employee Discount ₹0 per share
Issue Type Book Building
Minimum Investment ₹14070 / 1 Lots
Maximum Investment ₹196980 / 14 Lots
Fresh Issue ₹300 Crores
Offer For Sale ₹[-] Crores
Retail Discount ₹0 Crores
Shareholding Pre Issue 308417160 Shares
Shareholding Post Issue 315879846 Shares

About Dr Agarwal's Health Care Ltd IPO

Founding Head: 2010

Managing Director: [-]

DR AGARWAL'S HEALTH CARE LIMITED Timeline

Important dates for allocation and IPO listing.

29th Jan

IPO Opens

31st Jan

IPO Close

1st Feb

Allotment Date

3rd Feb

Initiation of Refund

3rd Feb

Credit of Shares to Demat Account

-

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 37.72 32.45
Public Group 62.28 67.55

Dr Agarwal's Health Care Ltd IPO Reservation

QIB Shares Offered 14519199(19.28%)
NII (HNI) Shares Offered 10889400(14.46%)
Retail Shares Offered 25408600(33.74%)
Anchor Investor Shares Offered 21778800(28.92%)
Total Shares Offered 75304968
Total Shares With Anchor Investor 75304968

Dr Agarwal's Health Care Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 35 ₹14070
Retail (Max) 14 490 ₹196980
S HNI (Min) 15 525 ₹211050
S HNI (Max) 71 2485 ₹998970
B HNI (MIN) 72 2520 ₹1013040

Dr Agarwal's Health Care Ltd IPO Anchor Investor Details

Bid Date 28 January 2025
Shares Offered 2,17,78,798
Anchor Portion Size 875.5076796

Dr Agarwal's Health Care Ltd IPO Registrar

KFin Techologies Ltd
Phone Number +91 40 6716 2222
Email Id einward.ris@kfintech.com
Our Website www.kfintech.com

Dr Agarwal's Health Care Ltd IPO Lead Manager

1. Kotak Mahindra Capital Company Ltd

2. Morgan Stanley India Company Pvt Ltd

3. Jefferies India Pvt Ltd

4. Motilal Oswal Investment Advisors Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Dr Agarwal's Health Care Ltd Financial Information

Period Ended March 31, 2024 March 31, 2023 March 31,
Net Worth ₹1227.21 ₹561.56
Reserves and Surplus ₹1217.88 ₹553.63
Total Borrowing ₹331.98 ₹307.25

Dr Agarwal's Health Care Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 14519200 67361280 4.6395
Non Institutional Investors (NIIs) 10889400 4307310 0.3956
NII(Bid amount of more than Ten Lakh Rupees) 7259600 2285955 0.3149
NII(Bid amount of more than 2 Lakh < 10 Rupees) 3629800 2021355 0.5569
Retail Individual Investors (RIIs) 25408599 10540285 0.4148
Total 53526172 83218380 1.5547

Strength of Dr Agarwal's Health Care Ltd

1. Largest eyecare services provider in India with a trusted brand.

2. End-to-end, comprehensive eyecare services offering.

3. Scalable, asset-light, hub-and-spoke operating model.

4. Proven clinical excellence driven by a strong clinical board and history of surgical innovations.

5. Doctor-promoters leading a team of qualified medical professionals and supported by an experienced management.

6. Proven track record of delivering organic growth, integrating and scaling acquisitions and improving operating profitability.

Risks Involved

1. The company engage doctors through retainership arrangements and there is no assurance that its doctors will not prematurely terminate their arrangements with it. If the company is not able to attract and retain its doctors and other medical professionals, the company business, financial condition, results of operations and cash flows may be adversely affected.

2. The company business depends on the strength of the company brand equity and reputation. Failures to maintain and enhance its brand equity and reputation, including due to negative publicity, may adversely affect its business, reputation, financial condition, results of operations and prospects.

3. The company operates in a regulated industry, and its failures to comply with applicable safety, health, environmental, labor and other regulations, or to obtain or renew approvals, may adversely affect its business, reputation, financial condition, results of operations and cash flows.

4. A significant majority of its Facilities are located in the states of Tamil Nadu (in particular, Chennai), Maharashtra and Karnataka in India and any adverse developments in relation to these Facilities could adversely affect its business, financial condition, results of operations and cash flows.

5. The company is exposed to legal claims and regulatory actions arising from the provision of healthcare services and may be subject to liabilities arising from claims of malpractice and medical negligence which could adversely affect its business, financial condition, results of operations, cash flows, reputation and prospects.

6. Its international operations expose it to management, legal, tax, political and economic risks, and its failure to address such risks could adversely affect the company business, results of operations, financial condition and cash flows.

7. Its hub-and-spoke model may not be successful and the company may not be able to expand into new geographic regions, which could adversely affect its business, financial condition and results of operations.

8. The company has pursued and will likely continue to pursue strategic acquisitions for inorganic growth. Its inability to successfully identify, acquire and integrate suitable opportunities on commercially reasonable terms in the future could adversely affect its business, financial condition, cash flows and results of operations.

9. Its historical performance is not indicative of the company future growth or financial results and if its fail to manage the company growth or implement its growth strategies, the company business, financial condition and results of operations may be adversely affected.

10. The company is exposed to credit risks in respect of payments from third parties including under central and state government schemes, government corporations, insurance companies and third party administrators. If the company does not receive payments on a timely basis, its business, financial condition, results of operations, cash flows and prospects may be adversely affected.

Why should you invest in

-

Dr Agarwal's Health Care Ltd Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023 2022
Total Assets 2752.82 1825.17 1026.13
Total Liabilities 2752.82 1825.17 1026.13
Total Expenses 1235.88 947.9 657.02
Total Revenue 
1376.45 1031.49 713.78
Profit After Tax 83.06 94.1 37.69
EBITDA 406.55 283.86 199.82
Adjusted EBITDA 0 0 0

DR AGARWAL'S HEALTH CARE LIMITED IPO Contact Details

Dr Agarwal's Health Care Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2025-02-04 544350 AGARWALEYE
INE943P01029
₹402 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹402 ₹402
Open ₹396.9 ₹402
Low ₹370.1 ₹370.2
High ₹412.75 ₹412.9
Low ₹370.1 ₹370.2

Frequently Asked Questions

What is Dr Agarwal's Health Care Ltd IPO?

Answer Field

Dr Agarwal's Health Care Ltd IPO is a Mainboard IPO of 7,53,04,968 equity shares of a face value of ₹1 aggregating up to ₹3027.26 Crores. The issue is priced at ₹402 to ₹402 per share. The minimum order quantity is 35 Shares. The IPO opens on January 29, 2025, and closes on January 31, 2025. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Dr Agarwal's Health Care Ltd IPO will open?

Answer Field

The Dr Agarwal's Health Care Ltd IPO opens on January 29, 2025 and closes on January 31, 2025.

What is the lot size of Dr Agarwal's Health Care Ltd?

Answer Field

Dr Agarwal's Health Care Ltd lot size is 35 shares, and the minimum amount required is ₹14,070.

How to apply for Dr Agarwal's Health Care Ltd IPO?

Answer Field

You can apply in Dr Agarwal's Health Care Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Dr Agarwal's Health Care Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Dr Agarwal's Health Care Ltd IPO will be done on February 01, 2025, and the allotted shares will be credited to your demat account by February 03, 2025.

When is Dr Agarwal's Health Care Ltd IPO listing date?

Answer Field

The Dr Agarwal's Health Care Ltd listing date is February 04, 2025.

Who is the registrar of Dr Agarwal's Health Care Ltd IPO?

Answer Field

The registrar of Dr Agarwal's Health Care Ltd IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Kotak Mahindra Capital Company Ltd,Morgan Stanley India Company Pvt Ltd,Jefferies India Pvt Ltd,Motilal Oswal Investment Advisors Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Dr Agarwal's Health Care Ltd IPO?

Answer Field

The fresh issue size is ₹300 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Dr Agarwal's Health Care Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 35 shares and ₹14,070 amount.

How can I approve the UPI mandate request for Dr Agarwal's Health Care Ltd IPO?

Answer Field

To apply for Dr Agarwal's Health Care Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Dr Agarwal's Health Care Ltd?

Answer Field

The price of each Dr Agarwal's Health Care Ltd share will be ranging in between ₹402 to ₹402 per share.

What is the cut-off time for the UPI mandate for Dr Agarwal's Health Care Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, January 31, 2025.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • BALAJI PHOSPHATES LIMITEDSME IPO

  • Bidding Dates

    28th Feb 2025 - 3rd Mar 2025

  • Price Range

    ₹66.0 - 70.0

  • IPO Size

    ₹50,11,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • VOLER CAR LIMITEDSME IPO

  • Issue Price

    90.00

  • Listing Day Close

    91.45

  • Listing Day (Gain/Loss)

    1.11

  • CLN ENERGY LIMITEDSME IPO

  • Issue Price

    250.00

  • Listing Day Close

    254.15

  • Listing Day (Gain/Loss)

    1.60

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 Lacs+ Users

icon-with-text

4.1+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text